Transdermal Patches With Cannabinoids

What a transdermal patch is

Transdermal means "through the skin." A transdermal patch is an adhesive product meant to deliver a compound through the skin and into the bloodstream, so it can act throughout the body (systemic delivery). That is different from a cream meant to act where it is rubbed in. Reviews of transdermal systems describe them as made of an adhesive, an active drug and often "enhancing agents" that help the drug cross skin. [1] Cannabinoid patches are sold with CBD, THC or other compounds. See topical vs transdermal products. Evidence labels used: promising but limited, insufficient evidence, marketing claim.

Why skin is hard to cross

Cannabinoids dissolve in oils and skin is a barrier. A 2024 review of transdermal cannabinoid delivery said detailed clinical trials are limited and that more work is needed on patch design, patch-drug interaction, effectiveness, safety and ways to increase skin permeation. [2]

What human research exists

The study we found measured blood levels, not health benefits.

• Design. A single-arm, open-label exploratory study in healthy adults (mean age about 39.5) applied a transdermal delivery system containing 100 mg CBD and 100 mg THC. This is a study amount, not a recommendation. [3]
• Findings. Both compounds appeared in the blood. Timing varied widely, with time to peak level averaging 8 hours but ranging from 10 minutes to 12 hours, and the spread between individuals was large. No psychoactive effects were reported and the system was described as well tolerated in this group. [3]
• Limits. One product, no comparison group, healthy volunteers, a short follow-up. It does not show that a patch treats any condition. Label: insufficient evidence of benefit.

What is not known

• Whether any marketed hemp or CBD patch delivers what its label says. See certificates of analysis and adulterated and mislabeled products.
• How long effects last, how much varies from person to person, or what happens if the patch is warmed or worn on damaged skin: we did not find sources on these.
• Whether patches change drug-test results; see cannabis and drug testing.

Safety

• Skin reactions. A clinical update on transdermal systems says they can cause irritant and allergic contact dermatitis, because occlusion and repeated placement in the same spot favor sensitization, and any of the adhesive, the drug or the enhancers can be responsible. [1] See topical product safety.
• Because a patch can reach the bloodstream, the same cautions apply as for other forms: medicine interactions (CBD and medication interactions), pregnancy and breastfeeding, and THC effects (see THC). Ask a clinician or pharmacist before use if you take prescription medicines.
• Regulation (US, read 2026-10-22). The FDA says Epidiolex is the only FDA-approved drug containing CBD and that it has issued warning letters over CBD products marketed for therapeutic uses. [4] We did not read a regulator page about patches specifically; laws elsewhere differ and change. This is not legal advice.